Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

1 to 25 of 921 results

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

Vanda and Novartis to settle arbitration, with rights to Fanapt returned

23-12-2014

US biopharma firm Vanda Pharmaceuticals says it has reached a settlement agreement with Swiss drug major…

FanaptLegalLicensingMergers & AcquisitionsNeurologicalNovartisPharmaceuticalVanda Pharmaceuticals

FTC puts conditions on Eli Lilly’s proposed acquisition of Novartis Animal Health

23-12-2014

US pharma major Eli Lilly has agreed to divest its Sentinel product line of medications for treating…

Eli LillyMergers & AcquisitionsNovartisPharmaceuticalUSA

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

KCR acquires project portfolio from Ukraine’s CRO AXIS

KCR acquires project portfolio from Ukraine’s CRO AXIS

17-12-2014

KCR, a Poland-based contract research organization (CRO), has recently acquired the whole portfolio of…

AXIS GroupKCRMergers & AcquisitionsPharmaceuticalResearchUkraine

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

Sosei to acquire Japanese peptide technology company Jitsubo

Sosei to acquire Japanese peptide technology company Jitsubo

12-12-2014

Japanese biopharma company Sosei says its board of directors has resolved to acquire existing shares…

BiotechnologyJapanJitsuboMergers & AcquisitionsSosei

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

09-12-2014

The Indian Competition Commission has granted domestic generics company Sun Pharmaceutical Industries…

IndiaMergers & AcquisitionsPharmaceuticalRanbaxySun Pharmaceutical

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion

08-12-2014

Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsZerbaxa

Sources say Merck to buy Cubist in $7 billion deal

Sources say Merck to buy Cubist in $7 billion deal

08-12-2014

Sources close to the matter say pharma giant Merck & Co has entered negotiations with Cubist Pharmaceuticals…

CubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceuticalUSA

GlaxoSmithKline abandons plans to divest Established Products portfolio

05-12-2014

In what has come as something of a surprise, UK pharma major GlaxoSmithKline has abandoned its plan to…

EuropeGlaxoSmithKlineMergers & AcquisitionsNorth AmericaPharmaceutical

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

Roche enters NIPT sector with acquisition of Ariosa Diagnostics

03-12-2014

Swiss pharma major Roche has acquired Ariosa Diagnostics, a privately-held company based in San Jose,…

Ariosa DiagnosticsMergers & AcquisitionsPharmaceuticalRocheUSAWomen's Health

Otsuka acquires Avanir for $3.5 billion

Otsuka acquires Avanir for $3.5 billion

02-12-2014

The US subsidiary of Japanese drug maker Otsuka has acquired US CNS specialist Avanir Pharmaceuticals…

AvanirJapanMergers & AcquisitionsNeurologicalNuedextaOtsuka PharmaceuticalPharmaceuticalUSA

Cocrystal Pharma and RFS Pharma complete merger

28-11-2014

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately…

Anti-viralsBiotechnologyCocrystal PharmaMergers & AcquisitionsRFS Pharma

FTC puts conditions on GSK/Novartis consumer JV

27-11-2014

The US Federal Trade Commission has voted to approve UK pharma giant GlaxoSmithKline’s proposed acquisition…

Dr Reddy's LaboratoriesGlaxoSmithKlineHabitrolMergers & AcquisitionsNicodermNovartisPharmaceuticalRegulationUSAVaccines

Recipharm acquires Flamel Technologies facility in France

27-11-2014

Swedish pharmaceutical contract development and manufacturing organization Recipharm AB and French drug…

Flamel TechnologiesFranceMergers & AcquisitionsPharmaceuticalProductionRecipharm

Big pharma increasingly collaborating with Indian companies

Big pharma increasingly collaborating with Indian companies

26-11-2014

Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

Gilead SciencesIndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

Apellis Pharma to acquire former parent Potentia

Apellis Pharma to acquire former parent Potentia

26-11-2014

USA-based Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals,…

Apellis PharmaceuticalsMergers & AcquisitionsOphthalmicsPharmaceuticalPotentia PharmaceuticalsUSA

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

BioMarin to acquire Prosensa for up to $840 million

BioMarin to acquire Prosensa for up to $840 million

24-11-2014

US drugmaker BioMarin Pharmaceutical has entered into a definitive agreement to purchase all of the outstanding…

BioMarin PharmaceuticaldrisapersenMergers & AcquisitionsPharmaceuticalProsensaRare diseases

1 to 25 of 921 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top